Matthew Herper

Senior Writer, Medicine at STAT News. This is biology's century; Every data point has a face.

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications
N/A

Published Content

192
statnews.com
Article
Amarin’s Vascepa prevents second and third heart attacks in analysis
March, 18 2019
statnews.com
Article
Next for Apple Watch: a clinical trial with J&J to track heart health
March, 16 2019
statnews.com
Article
Giant study shows Apple Watch can spot important heart rhythm changes
March, 16 2019
statnews.com
Article
Storm clouds gather over pharma companies as pace of price hikes slows
February, 5 2019
statnews.com
Article
The modern tragedy of fake cancer cures
February, 1 2019
statnews.com
Article
Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics
January, 7 2019
forbes.com
Article
What Can You Do For Your Loved Ones When You’re Dying Of Cancer?
December, 21 2018
forbes.com
Article
Glaxo And Pfizer Raise The Question: Should Drug Companies Sell Toothpaste and Chapstick?
December, 19 2018
forbes.com
Article
A Year In, Novartis’ Boss Faces The World
December, 19 2018
forbes.com
Article
FDA Names Flatiron Health Executive Amy Abernethy Deputy Commissioner
December, 17 2018
forbes.com
Article
Before He Died, Paul Allen Gifted $125 Million To A New Institute To Study The Immune System
December, 12 2018
forbes.com
Article
Buzzy Startup 10x Genomics Buys Spatial Transcriptomics In Bet On Genetic Tools
December, 10 2018
forbes.com
Article
GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics
December, 3 2018
forbes.com
Article
A Billionaire Vs. Drug Firms; Throwing Pharma Under The Bus; What The First iPhone Means For Healthcare
November, 30 2018
forbes.com
Article
Loxo And Bayer's Amazing Drug Has An Expensive Price
November, 27 2018
forbes.com
Article
Is Amarin’s Fish-Oil-Derived Drug A Historic Breakthrough Or Not? It’s Complicated
November, 20 2018
forbes.com
Article
The Forbes Healthcare Summit 2018: The Draft Agenda
November, 14 2018
forbes.com
Article
At 24, Two Entrepreneurs Took On Cancer. At 32, They’re Worth Hundreds Of Millions
November, 14 2018
forbes.com
Article
A $3 Billion Startup's Shares Gain On Hopes For A Cancer Blood Test
November, 12 2018
forbes.com
Article
Amarin's Fish-Oil-Derived Drug Shows Great Promise—With Big Caveats
November, 10 2018
forbes.com
Article
DNA Sequencing Giant Illumina Will Buy Pacific Biosciences For $1.2 Billion – Exclusive CEO Interview
November, 1 2018
forbes.com
Article
Swiss Startup Aims To Help Paralyzed People Walk
November, 1 2018
forbes.com
Article
Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox
October, 25 2018
forbes.com
Article
FDA Experts May Reconsider Diabetes Drug Safety Rules
October, 24 2018
forbes.com
Article
In Unprecedented Move, Amgen Cuts Price Of Cholesterol Drug Repatha By 60%
October, 24 2018
forbes.com
Article
A New Targeted Cancer Company To Watch
October, 19 2018
forbes.com
Article
Researchers Behind Spinraza Win Breakthrough Prize
October, 17 2018
forbes.com
Article
How Paul Allen Taught Me To Peel An Orange
October, 16 2018
forbes.com
Article
A Preview Of The 2018 Forbes Healthcare Summit
October, 10 2018
forbes.com
Article
Sarepta Gene Therapy Appears To Help Fourth Boy With Duchenne Muscular Dystrophy
October, 3 2018
forbes.com
Article
Sarepta Gene Therapy Appears To Help Fourth Boy With Duchenne Muscular Dystrophy
October, 3 2018
forbes.com
Article
CRISPR-Based Drugmaker Raises $80 Million
September, 28 2018
forbes.com
Article
Alnylam Posts Positive Data On Second Drug, Plans FDA Meeting
September, 27 2018
forbes.com
Article
Aiming To Revolutionize Medical Ultrasound, Butterfly Raises $250 Million At A $1.25 Billion Valuation
September, 27 2018
forbes.com
Article
In Blowout, Amarin's Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In Study
September, 24 2018
forbes.com
Article
Paralyzed Patients Go From Wheelchairs To Walkers With Experimental Treatment
September, 24 2018
forbes.com
Article
Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup's Board
September, 21 2018
forbes.com
Article
At Joe Biden's Urging, Airbnb, WeWork, And Others Commit To Help Cancer Patients
September, 21 2018
forbes.com
Article
A $100 Million Biotech Deal Is Also A Tale Of Two Executives Facing Their Kids' Deadly Diseases
September, 20 2018
forbes.com
Article
For A New Device To Treat Maternal Bleeding, A Young Entrepreneur's Big Step Was Letting Go
September, 20 2018
forbes.com
Article
If It Wanted To, The FDA Could Destroy E-Cigarette Makers
September, 12 2018
forbes.com
Article
Semiautomatic Rifles May Make Mass Shootings Deadlier, Study Says
September, 11 2018
forbes.com
Article
How To Really Take Medical Conflicts Of Interest Seriously
September, 10 2018
forbes.com
Article
Of Vampires And The Challenges Of Longevity Drugs
September, 7 2018
forbes.com
Article
Pharma Billionaire Charged With Penny Stock Fraud
September, 7 2018
forbes.com
Article
Jackie Fouse, Admired By Investors, To Become CEO Of Biotech Agios
September, 4 2018
forbes.com
Article
Pfizer Drug Reduces Death Rate In Patients With Hearts Damaged By Protein Clumps
August, 27 2018
forbes.com
Article
Esperion's Cholesterol Combo Pill Cuts Bad Cholesterol 35%
August, 27 2018
forbes.com
Article
The Agonizingly Slow Progress Against The Cancer That Killed Aretha Franklin
August, 16 2018
forbes.com
Article
A Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free.
August, 13 2018
Authorship Stats
2Sites192Projects118,267Words
About
Matthew Herper is a writer who has produced content for statnews.com and forbes.com
Key Phrases
Chief Executive, Heart Attacks, Gene Therapy, Drug Administration, Clinical Trials, Drug Companies, Cancer Drugs, England Journal, New England, Health Care
© ClearVoice, Inc.